Back to Search
Start Over
Consensus guidelines for the diagnosis and management of isolated sulfite oxidase deficiency and molybdenum cofactor deficiencies.
- Source :
- Journal of Inherited Metabolic Disease; Jul2024, Vol. 47 Issue 4, p598-623, 26p
- Publication Year :
- 2024
-
Abstract
- Sulfite intoxication is the hallmark of four ultrarare disorders that are caused by impaired sulfite oxidase activity due to genetic defects in the synthesis of the molybdenum cofactor or of the apoenzyme sulfite oxidase. Delays on the diagnosis of these disorders are common and have been caused by their unspecific presentation of acute neonatal encephalopathy with high early mortality, followed by the evolution of dystonic cerebral palsy and also by the lack of easily available and reliable diagnostic tests. There is significant variation in survival and in the quality of symptomatic management of affected children. One of the four disorders, molybdenum cofactor deficiency type A (MoCD‐A) has recently become amenable to causal treatment with synthetic cPMP (fosdenopterin). The evidence base for the rational use of cPMP is very limited. This prompted the formulation of these clinical guidelines to facilitate diagnosis and support the management of patients. The guidelines were developed by experts in diagnosis and treatment of sulfite intoxication disorders. It reflects expert consensus opinion and evidence from a systematic literature search. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01418955
- Volume :
- 47
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- Journal of Inherited Metabolic Disease
- Publication Type :
- Academic Journal
- Accession number :
- 178468631
- Full Text :
- https://doi.org/10.1002/jimd.12730